img

Global Premenstrual Syndrome Medicine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Premenstrual Syndrome Medicine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Premenstrual Syndrome Medicine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Premenstrual Syndrome Medicine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Premenstrual Syndrome Medicine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Premenstrual Syndrome Medicine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Premenstrual Syndrome Medicine include Asarina Pharma AB and Pherin Pharmaceuticals Inc etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Premenstrual Syndrome Medicine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Premenstrual Syndrome Medicine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Premenstrual Syndrome Medicine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Premenstrual Syndrome Medicine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Asarina Pharma AB
Pherin Pharmaceuticals Inc
By Type
PH-80PMD
Estrogen
Progesterone
Others
By Application
Home Care
Hospital
Clinic
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Premenstrual Syndrome Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Premenstrual Syndrome Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Premenstrual Syndrome Medicine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Premenstrual Syndrome Medicine Definition
1.2 Market by Type
1.2.1 Global Premenstrual Syndrome Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 PH-80PMD
1.2.3 Estrogen
1.2.4 Progesterone
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Premenstrual Syndrome Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Home Care
1.3.3 Hospital
1.3.4 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Premenstrual Syndrome Medicine Sales
2.1 Global Premenstrual Syndrome Medicine Revenue Estimates and Forecasts 2018-2034
2.2 Global Premenstrual Syndrome Medicine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Premenstrual Syndrome Medicine Revenue by Region
2.3.1 Global Premenstrual Syndrome Medicine Revenue by Region (2018-2024)
2.3.2 Global Premenstrual Syndrome Medicine Revenue by Region (2024-2034)
2.4 Global Premenstrual Syndrome Medicine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Premenstrual Syndrome Medicine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Premenstrual Syndrome Medicine Sales Quantity by Region
2.6.1 Global Premenstrual Syndrome Medicine Sales Quantity by Region (2018-2024)
2.6.2 Global Premenstrual Syndrome Medicine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Premenstrual Syndrome Medicine Sales Quantity by Manufacturers
3.1.1 Global Premenstrual Syndrome Medicine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Premenstrual Syndrome Medicine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Premenstrual Syndrome Medicine Sales in 2022
3.2 Global Premenstrual Syndrome Medicine Revenue by Manufacturers
3.2.1 Global Premenstrual Syndrome Medicine Revenue by Manufacturers (2018-2024)
3.2.2 Global Premenstrual Syndrome Medicine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Premenstrual Syndrome Medicine Revenue in 2022
3.3 Global Premenstrual Syndrome Medicine Sales Price by Manufacturers
3.4 Global Key Players of Premenstrual Syndrome Medicine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Premenstrual Syndrome Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Premenstrual Syndrome Medicine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Premenstrual Syndrome Medicine, Product Offered and Application
3.8 Global Key Manufacturers of Premenstrual Syndrome Medicine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Premenstrual Syndrome Medicine Sales Quantity by Type
4.1.1 Global Premenstrual Syndrome Medicine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Premenstrual Syndrome Medicine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Premenstrual Syndrome Medicine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Premenstrual Syndrome Medicine Revenue by Type
4.2.1 Global Premenstrual Syndrome Medicine Historical Revenue by Type (2018-2024)
4.2.2 Global Premenstrual Syndrome Medicine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Premenstrual Syndrome Medicine Revenue Market Share by Type (2018-2034)
4.3 Global Premenstrual Syndrome Medicine Price by Type
4.3.1 Global Premenstrual Syndrome Medicine Price by Type (2018-2024)
4.3.2 Global Premenstrual Syndrome Medicine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Premenstrual Syndrome Medicine Sales Quantity by Application
5.1.1 Global Premenstrual Syndrome Medicine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Premenstrual Syndrome Medicine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Premenstrual Syndrome Medicine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Premenstrual Syndrome Medicine Revenue by Application
5.2.1 Global Premenstrual Syndrome Medicine Historical Revenue by Application (2018-2024)
5.2.2 Global Premenstrual Syndrome Medicine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Premenstrual Syndrome Medicine Revenue Market Share by Application (2018-2034)
5.3 Global Premenstrual Syndrome Medicine Price by Application
5.3.1 Global Premenstrual Syndrome Medicine Price by Application (2018-2024)
5.3.2 Global Premenstrual Syndrome Medicine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Premenstrual Syndrome Medicine Sales by Company
6.1.1 North America Premenstrual Syndrome Medicine Revenue by Company (2018-2024)
6.1.2 North America Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024)
6.2 North America Premenstrual Syndrome Medicine Market Size by Type
6.2.1 North America Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2034)
6.2.2 North America Premenstrual Syndrome Medicine Revenue by Type (2018-2034)
6.3 North America Premenstrual Syndrome Medicine Market Size by Application
6.3.1 North America Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2034)
6.3.2 North America Premenstrual Syndrome Medicine Revenue by Application (2018-2034)
6.4 North America Premenstrual Syndrome Medicine Market Size by Country
6.4.1 North America Premenstrual Syndrome Medicine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Premenstrual Syndrome Medicine Revenue by Country (2018-2034)
6.4.3 North America Premenstrual Syndrome Medicine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Premenstrual Syndrome Medicine Sales by Company
7.1.1 Europe Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024)
7.1.2 Europe Premenstrual Syndrome Medicine Revenue by Company (2018-2024)
7.2 Europe Premenstrual Syndrome Medicine Market Size by Type
7.2.1 Europe Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2034)
7.2.2 Europe Premenstrual Syndrome Medicine Revenue by Type (2018-2034)
7.3 Europe Premenstrual Syndrome Medicine Market Size by Application
7.3.1 Europe Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2034)
7.3.2 Europe Premenstrual Syndrome Medicine Revenue by Application (2018-2034)
7.4 Europe Premenstrual Syndrome Medicine Market Size by Country
7.4.1 Europe Premenstrual Syndrome Medicine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Premenstrual Syndrome Medicine Revenue by Country (2018-2034)
7.4.3 Europe Premenstrual Syndrome Medicine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Premenstrual Syndrome Medicine Sales by Company
8.1.1 China Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024)
8.1.2 China Premenstrual Syndrome Medicine Revenue by Company (2018-2024)
8.2 China Premenstrual Syndrome Medicine Market Size by Type
8.2.1 China Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2034)
8.2.2 China Premenstrual Syndrome Medicine Revenue by Type (2018-2034)
8.3 China Premenstrual Syndrome Medicine Market Size by Application
8.3.1 China Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2034)
8.3.2 China Premenstrual Syndrome Medicine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Premenstrual Syndrome Medicine Sales by Company
9.1.1 APAC Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024)
9.1.2 APAC Premenstrual Syndrome Medicine Revenue by Company (2018-2024)
9.2 APAC Premenstrual Syndrome Medicine Market Size by Type
9.2.1 APAC Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2034)
9.2.2 APAC Premenstrual Syndrome Medicine Revenue by Type (2018-2034)
9.3 APAC Premenstrual Syndrome Medicine Market Size by Application
9.3.1 APAC Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2034)
9.3.2 APAC Premenstrual Syndrome Medicine Revenue by Application (2018-2034)
9.4 APAC Premenstrual Syndrome Medicine Market Size by Region
9.4.1 APAC Premenstrual Syndrome Medicine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Premenstrual Syndrome Medicine Revenue by Region (2018-2034)
9.4.3 APAC Premenstrual Syndrome Medicine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales by Company
10.1.1 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Market Size by Type
10.2.1 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Market Size by Application
10.3.1 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Market Size by Country
10.4.1 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Asarina Pharma AB
11.1.1 Asarina Pharma AB Company Information
11.1.2 Asarina Pharma AB Overview
11.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Asarina Pharma AB Premenstrual Syndrome Medicine Products and Services
11.1.5 Asarina Pharma AB Premenstrual Syndrome Medicine SWOT Analysis
11.1.6 Asarina Pharma AB Recent Developments
11.2 Pherin Pharmaceuticals Inc
11.2.1 Pherin Pharmaceuticals Inc Company Information
11.2.2 Pherin Pharmaceuticals Inc Overview
11.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Products and Services
11.2.5 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine SWOT Analysis
11.2.6 Pherin Pharmaceuticals Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Premenstrual Syndrome Medicine Value Chain Analysis
12.2 Premenstrual Syndrome Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Premenstrual Syndrome Medicine Production Mode & Process
12.4 Premenstrual Syndrome Medicine Sales and Marketing
12.4.1 Premenstrual Syndrome Medicine Sales Channels
12.4.2 Premenstrual Syndrome Medicine Distributors
12.5 Premenstrual Syndrome Medicine Customers
13 Market Dynamics
13.1 Premenstrual Syndrome Medicine Industry Trends
13.2 Premenstrual Syndrome Medicine Market Drivers
13.3 Premenstrual Syndrome Medicine Market Challenges
13.4 Premenstrual Syndrome Medicine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of PH-80PMD
Table 3. Major Manufacturers of Estrogen
Table 4. Major Manufacturers of Progesterone
Table 5. Major Manufacturers of Others
Table 6. Global Premenstrual Syndrome Medicine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Premenstrual Syndrome Medicine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Premenstrual Syndrome Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Premenstrual Syndrome Medicine Revenue Market Share by Region (2018-2024)
Table 10. Global Premenstrual Syndrome Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Premenstrual Syndrome Medicine Revenue Market Share by Region (2024-2034)
Table 12. Global Premenstrual Syndrome Medicine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Pcs)
Table 13. Global Premenstrual Syndrome Medicine Sales by Region (2018-2024) & (K Pcs)
Table 14. Global Premenstrual Syndrome Medicine Sales Market Share by Region (2018-2024)
Table 15. Global Premenstrual Syndrome Medicine Sales by Region (2024-2034) & (K Pcs)
Table 16. Global Premenstrual Syndrome Medicine Sales Market Share by Region (2024-2034)
Table 17. Global Premenstrual Syndrome Medicine Sales Quantity by Manufacturers (2018-2024) & (K Pcs)
Table 18. Global Premenstrual Syndrome Medicine Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Premenstrual Syndrome Medicine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Premenstrual Syndrome Medicine Revenue Share by Manufacturers (2018-2024)
Table 21. Global Premenstrual Syndrome Medicine Price by Manufacturers 2018-2024 (USD/Pcs)
Table 22. Global Key Players of Premenstrual Syndrome Medicine, Industry Ranking, 2021 VS 2022
Table 23. Global Premenstrual Syndrome Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Premenstrual Syndrome Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Syndrome Medicine as of 2022)
Table 25. Global Key Manufacturers of Premenstrual Syndrome Medicine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Premenstrual Syndrome Medicine, Product Offered and Application
Table 27. Global Key Manufacturers of Premenstrual Syndrome Medicine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 30. Global Premenstrual Syndrome Medicine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global Premenstrual Syndrome Medicine Sales Quantity Share by Type (2018-2024)
Table 32. Global Premenstrual Syndrome Medicine Sales Quantity Share by Type (2024-2034)
Table 33. Global Premenstrual Syndrome Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Premenstrual Syndrome Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Premenstrual Syndrome Medicine Revenue Share by Type (2018-2024)
Table 36. Global Premenstrual Syndrome Medicine Revenue Share by Type (2024-2034)
Table 37. Premenstrual Syndrome Medicine Price by Type (2018-2024) & (USD/Pcs)
Table 38. Global Premenstrual Syndrome Medicine Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 40. Global Premenstrual Syndrome Medicine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global Premenstrual Syndrome Medicine Sales Quantity Share by Application (2018-2024)
Table 42. Global Premenstrual Syndrome Medicine Sales Quantity Share by Application (2024-2034)
Table 43. Global Premenstrual Syndrome Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Premenstrual Syndrome Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Premenstrual Syndrome Medicine Revenue Share by Application (2018-2024)
Table 46. Global Premenstrual Syndrome Medicine Revenue Share by Application (2024-2034)
Table 47. Premenstrual Syndrome Medicine Price by Application (2018-2024) & (USD/Pcs)
Table 48. Global Premenstrual Syndrome Medicine Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America Premenstrual Syndrome Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 51. North America Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 52. North America Premenstrual Syndrome Medicine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America Premenstrual Syndrome Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Premenstrual Syndrome Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 56. North America Premenstrual Syndrome Medicine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America Premenstrual Syndrome Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Premenstrual Syndrome Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Premenstrual Syndrome Medicine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Premenstrual Syndrome Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Premenstrual Syndrome Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Premenstrual Syndrome Medicine Sales Quantity by Country (2018-2024) & (K Pcs)
Table 63. North America Premenstrual Syndrome Medicine Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 65. Europe Premenstrual Syndrome Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 67. Europe Premenstrual Syndrome Medicine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe Premenstrual Syndrome Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Premenstrual Syndrome Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 71. Europe Premenstrual Syndrome Medicine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe Premenstrual Syndrome Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Premenstrual Syndrome Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Premenstrual Syndrome Medicine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Premenstrual Syndrome Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Premenstrual Syndrome Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Premenstrual Syndrome Medicine Sales Quantity by Country (2018-2024) & (K Pcs)
Table 78. Europe Premenstrual Syndrome Medicine Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 80. China Premenstrual Syndrome Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 82. China Premenstrual Syndrome Medicine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China Premenstrual Syndrome Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Premenstrual Syndrome Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 86. China Premenstrual Syndrome Medicine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China Premenstrual Syndrome Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Premenstrual Syndrome Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 90. APAC Premenstrual Syndrome Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 92. APAC Premenstrual Syndrome Medicine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC Premenstrual Syndrome Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Premenstrual Syndrome Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 96. APAC Premenstrual Syndrome Medicine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC Premenstrual Syndrome Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Premenstrual Syndrome Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Premenstrual Syndrome Medicine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Premenstrual Syndrome Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Premenstrual Syndrome Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Premenstrual Syndrome Medicine Sales Quantity by Region (2018-2024) & (K Pcs)
Table 103. APAC Premenstrual Syndrome Medicine Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Company (2018-2024) & (K Pcs)
Table 105. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Type (2018-2024) & (K Pcs)
Table 107. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Application (2018-2024) & (K Pcs)
Table 111. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Country (2018-2024) & (K Pcs)
Table 118. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Asarina Pharma AB Company Information
Table 120. Asarina Pharma AB Description and Overview
Table 121. Asarina Pharma AB Premenstrual Syndrome Medicine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Asarina Pharma AB Premenstrual Syndrome Medicine Product and Services
Table 123. Asarina Pharma AB Premenstrual Syndrome Medicine SWOT Analysis
Table 124. Asarina Pharma AB Recent Developments
Table 125. Pherin Pharmaceuticals Inc Company Information
Table 126. Pherin Pharmaceuticals Inc Description and Overview
Table 127. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product and Services
Table 129. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine SWOT Analysis
Table 130. Pherin Pharmaceuticals Inc Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Premenstrual Syndrome Medicine Distributors List
Table 134. Premenstrual Syndrome Medicine Customers List
Table 135. Premenstrual Syndrome Medicine Market Trends
Table 136. Premenstrual Syndrome Medicine Market Drivers
Table 137. Premenstrual Syndrome Medicine Market Challenges
Table 138. Premenstrual Syndrome Medicine Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Premenstrual Syndrome Medicine Product Picture
Figure 2. Global Premenstrual Syndrome Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Premenstrual Syndrome Medicine Market Share by Type in 2022 & 2034
Figure 4. PH-80PMD Product Picture
Figure 5. Estrogen Product Picture
Figure 6. Progesterone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Premenstrual Syndrome Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Premenstrual Syndrome Medicine Market Share by Application in 2022 & 2034
Figure 10. Home Care
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Premenstrual Syndrome Medicine Report Years Considered
Figure 14. Global Premenstrual Syndrome Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Premenstrual Syndrome Medicine Revenue 2018-2034 (US$ Million)
Figure 16. Global Premenstrual Syndrome Medicine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Premenstrual Syndrome Medicine Sales Quantity 2018-2034 (K Pcs)
Figure 18. Global Premenstrual Syndrome Medicine Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Premenstrual Syndrome Medicine Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Premenstrual Syndrome Medicine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 21. North America Premenstrual Syndrome Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Premenstrual Syndrome Medicine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. Europe Premenstrual Syndrome Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Premenstrual Syndrome Medicine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. China Premenstrual Syndrome Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Premenstrual Syndrome Medicine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. APAC Premenstrual Syndrome Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Premenstrual Syndrome Medicine Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Premenstrual Syndrome Medicine Revenue in 2022
Figure 32. Premenstrual Syndrome Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Premenstrual Syndrome Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Premenstrual Syndrome Medicine Revenue Market Share by Type (2018-2034)
Figure 35. Global Premenstrual Syndrome Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Premenstrual Syndrome Medicine Revenue Market Share by Application (2018-2034)
Figure 37. North America Premenstrual Syndrome Medicine Revenue Market Share by Company in 2022
Figure 38. North America Premenstrual Syndrome Medicine Sales Quantity Market Share by Company in 2022
Figure 39. North America Premenstrual Syndrome Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Premenstrual Syndrome Medicine Revenue Market Share by Type (2018-2034)
Figure 41. North America Premenstrual Syndrome Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Premenstrual Syndrome Medicine Revenue Market Share by Application (2018-2034)
Figure 43. North America Premenstrual Syndrome Medicine Revenue Share by Country (2018-2034)
Figure 44. North America Premenstrual Syndrome Medicine Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Premenstrual Syndrome Medicine Sales Quantity Market Share by Company in 2022
Figure 48. Europe Premenstrual Syndrome Medicine Revenue Market Share by Company in 2022
Figure 49. Europe Premenstrual Syndrome Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Premenstrual Syndrome Medicine Revenue Market Share by Type (2018-2034)
Figure 51. Europe Premenstrual Syndrome Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Premenstrual Syndrome Medicine Revenue Market Share by Application (2018-2034)
Figure 53. Europe Premenstrual Syndrome Medicine Revenue Share by Country (2018-2034)
Figure 54. Europe Premenstrual Syndrome Medicine Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 56. France Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 60. China Premenstrual Syndrome Medicine Sales Quantity Market Share by Company in 2022
Figure 61. China Premenstrual Syndrome Medicine Revenue Market Share by Company in 2022
Figure 62. China Premenstrual Syndrome Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Premenstrual Syndrome Medicine Revenue Market Share by Type (2018-2034)
Figure 64. China Premenstrual Syndrome Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Premenstrual Syndrome Medicine Revenue Market Share by Application (2018-2034)
Figure 66. APAC Premenstrual Syndrome Medicine Sales Quantity Market Share by Company in 2022
Figure 67. APAC Premenstrual Syndrome Medicine Revenue Market Share by Company in 2022
Figure 68. APAC Premenstrual Syndrome Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Premenstrual Syndrome Medicine Revenue Market Share by Type (2018-2034)
Figure 70. APAC Premenstrual Syndrome Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Premenstrual Syndrome Medicine Revenue Market Share by Application (2018-2034)
Figure 72. APAC Premenstrual Syndrome Medicine Revenue Share by Region (2018-2034)
Figure 73. APAC Premenstrual Syndrome Medicine Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 78. India Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Premenstrual Syndrome Medicine Revenue Share by Country (2018-2034)
Figure 87. Brazil Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Premenstrual Syndrome Medicine Revenue (2018-2034) & (US$ Million)
Figure 92. Premenstrual Syndrome Medicine Value Chain
Figure 93. Premenstrual Syndrome Medicine Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed